MeSH tree: G05.360.340.024.340.375.500.791
Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors," that control how those genes are read.
Oct 16, 2025
0
27
Researchers at the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can precisely block the interaction between the major cancer-driving gene RAS and a key pathway for tumor growth.
Oct 9, 2025
0
30
Every cell in the human body operates on an intricate internal schedule, governed by circadian rhythms that synchronize our biological processes with the 24-hour cycle of day and night. Coordinated by a master clock in the ...
Oct 6, 2025
0
0
Cancer kills more than 500,000 Americans each year. But today, UC San Francisco researchers are revolutionizing what we thought we knew about how cancer spreads, opening new paths to cures. The paper is published in the journal ...
Sep 23, 2025
0
1
Could a natural check on cancer be used to stop the disease? It's possible, but to leverage a system that nature designed, we must first understand it. Researchers led by a team at Purdue University are exploring a molecular ...
Aug 27, 2025
0
8
Australian researchers have used an innovative genome-wide screening approach to identify genes, and their encoded proteins, that play critical roles in the prevention of lymphoma development, revealing new potential treatment ...
Aug 21, 2025
0
8
University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a "two-in-one" molecule that can simultaneously turn off two notoriously difficult-to-target cancer-related genes, KRAS and MYC, ...
Aug 4, 2025
0
50
Northwestern Medicine investigators have discovered a new combination approach that may improve the efficacy of MYC inhibitor drugs for treating aggressive and treatment-resistant cancers, according to a recent Northwestern ...
Jul 31, 2025
0
69
Obesity elevates the risk of at least 13 major cancers, including those of the breast, colon and liver. It also impairs immune responses that target tumors and are stimulated by cancer immunotherapies. But it has long been ...
Jul 30, 2025
0
28
Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, published in the Journal ...
Jul 10, 2025
0
27
